Osteoglycin Inhibits the Progression of Lung Adenocarcinoma by Modulating ICAM1‐Mediated Cell Adhesion via the PI3K/AKT Pathway
Molecular Carcinogenesis · 2025
DOI: 10.1002/mc.70007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2025. Verfasst von Shangwei Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Huadong Hospital Affiliated to Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Proto-Oncogene Proteins c-akt, Lung Neoplasms, Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: This study was supported by Huadong Hospital Affiliated to Fudan University, Wu Jieping Medical Foundation and National Nature Cultivation Youth Project..
Abstract (Originalsprache)
Lung cancer is characterized by high aggressiveness and lethality, processing in‐depth molecular mechanism investigation is particularly necessary. In our study, we found that osteoglycin (OGN) deficiency is strongly associated with a poor prognosis in lung adenocarcinoma (LUAD). OGN overexpression could inhibit the proliferation, migration, and invasion of LUAD cells. Through transcriptome sequencing analysis and experimental validation, we revealed that such OGN ‐mediated tumor suppression effect was related to cell adhesion function induced by ICAM1 downregulation, along with regulation by the PI3K/AKT signaling pathway. The present study demonstrated the specific mechanism of OGN involvement in LUAD progression, providing new evidence and potential targets for research on cancer suppression in LUAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
- Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Respiratory Medicine, Shanghai Fengxian District Central Hospital, Shanghai, China.
ORCID-Profile: Shangwei Xu
Förderung
- This study was supported by Huadong Hospital Affiliated to Fudan University, Wu Jieping Medical Foundation and National Nature Cultivation Youth Project.
Zitieren
APA
Xu, S., Chen, C., Liu, H., Jiang, S., Li, Z., & Wu, Y. (2025). Osteoglycin Inhibits the Progression of Lung Adenocarcinoma by Modulating ICAM1‐Mediated Cell Adhesion via the PI3K/AKT Pathway. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70007
Vancouver
Xu S, Chen C, Liu H, Jiang S, Li Z, Wu Y. Osteoglycin Inhibits the Progression of Lung Adenocarcinoma by Modulating ICAM1‐Mediated Cell Adhesion via the PI3K/AKT Pathway. Molecular Carcinogenesis. 2025. doi:10.1002/mc.70007
BibTeX
@article{Xu2025,
author = {Xu, Shangwei and Chen, Chunji and Liu, Hongwei and Jiang, Shuai and Li, Zheng and Wu, Yun},
title = {Osteoglycin Inhibits the Progression of Lung Adenocarcinoma by Modulating ICAM1‐Mediated Cell Adhesion via the PI3K/AKT Pathway},
journal = {Molecular Carcinogenesis},
year = {2025},
doi = {10.1002/mc.70007}
}
EUVIMED